摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(3-methoxy-4-fluorophenyl)acetic acid | 900174-47-2

中文名称
——
中文别名
——
英文名称
2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(3-methoxy-4-fluorophenyl)acetic acid
英文别名
2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(4-fluoro-3-methoxyphenyl)acetic acid;2-[[1-[Bis[(2-methylpropan-2-yl)oxycarbonyl]amino]isoquinolin-6-yl]amino]-2-(4-fluoro-3-methoxyphenyl)acetic acid
2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(3-methoxy-4-fluorophenyl)acetic acid化学式
CAS
900174-47-2
化学式
C28H32FN3O7
mdl
——
分子量
541.576
InChiKey
HZKDSGNSMIUHAE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    39
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    127
  • 氢给体数:
    2
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(3-methoxy-4-fluorophenyl)acetic acid盐酸盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺N,N-二异丙基乙胺 、 sodium hydroxide 作用下, 以 四氢呋喃1,4-二氧六环甲醇乙酸乙酯 为溶剂, 反应 5.0h, 生成 (2R,3S)-1-((2R)-2-(1-aminoisoquinolin-6-ylamino)-2-(4-fluoro-3-methoxyphenyl)acetyl)-2-(2-(ethylsulfonyl)phenyl)pyrrolidine-3-carboxylic acid trifluoroacetic acid salt
    参考文献:
    名称:
    Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors
    摘要:
    Inhibitors of the Tissue Factor/Factor VIIa (TF-FVIIa) complex are promising novel anticoagulants that show excellent efficacy and minimal bleeding in preclinical models. On the basis of a zwitterionic phenylglycine acylsulfonamide 1, a phenylglycine benzylamide 2 was shown to possess improved permeability and oral bioavailability. Optimization of the benzylamide, guided by X-ray crystallography, led to a potent TF-FVIIa inhibitor 18i with promising oral bioavailability, but promiscuous activity in an in vitro safety panel of receptors and enzymes. Introducing an acid on the pyrrolidine ring, guided by molecular modeling, resulted in highly potent, selective, and efficacious TF-FVIIa inhibitors with clean in vitro safety profile. The pyrrolidine acid 20 showed a moderate clearance, low volume of distribution, and a short t(1/2) in dog PK studies.
    DOI:
    10.1021/ml400453z
  • 作为产物:
    描述:
    6-amino-1-(di-tert-butoxycarbonylamino)isoquinoline乙醛酸4-氟-3-甲氧基苯硼酸1,2-二氯乙烷 为溶剂, 反应 0.13h, 以50%的产率得到2-(1-di-tert-butoxycarbonylaminoisoquinolin-6-ylamino)-2-(3-methoxy-4-fluorophenyl)acetic acid
    参考文献:
    名称:
    Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
    摘要:
    本发明提供了式(I)或(IV)的新型苯基甘氨酰衍生物:或其立体异构体、互变异构体、药学上可接受的盐、溶剂合物或前药,其中变量W、W1、Y、Z、R7、R8、R9和R11如本文所定义。这些化合物是选择性因子VIIa的抑制剂,可用作药物。
    公开号:
    US20070003539A1
点击查看最新优质反应信息

文献信息

  • Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
    申请人:Zhang Xiaojun
    公开号:US20070003539A1
    公开(公告)日:2007-01-04
    The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W 1 , Y, Z, R 7 , R 8 , R 9 , and R 11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
    本发明提供了式(I)或(IV)的新型苯基甘氨酰衍生物:或其立体异构体、互变异构体、药学上可接受的盐、溶剂合物或前药,其中变量W、W1、Y、Z、R7、R8、R9和R11如本文所定义。这些化合物是选择性因子VIIa的抑制剂,可用作药物。
  • Phenylglycinamide derivatives useful as anticoagulants
    申请人:Zhang Xiaojun
    公开号:US20060166997A1
    公开(公告)日:2006-07-27
    The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
    本发明一般涉及抑制丝氨酸蛋白酶的苯基甘氨酰衍生物。具体而言,本发明涉及新型苯基甘氨酰衍生物及其类似物,其可用作凝血级联反应的丝氨酸蛋白酶酶的选择性抑制剂;例如凝血酶、第VIIa因子、第Xa因子、第XIa因子、第IXa因子和/或血浆激肽。特别是,它涉及到的化合物是第VIIa因子的抑制剂。本发明还涉及包含这些化合物的制药组合物及其使用方法。
  • WO2006/76246
    申请人:——
    公开号:——
    公开(公告)日:——
  • PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS
    申请人:Bristol-Myers Squibb Company
    公开号:EP1856096B1
    公开(公告)日:2010-09-01
  • PHENYLGLYCINAMIDE AND PYRIDYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS
    申请人:Bristol-Myers Squibb Company
    公开号:EP1910298B1
    公开(公告)日:2010-01-13
查看更多